Alejandro Javier Krolewiecki (Alejandro Krolewiecki, Alejandro J Krolewiecki)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Venues

PLoS neglected tropical diseases

Gates open research

Clinical pharmacology and therapeutics

PloS one

Universidad Nacional de Salta

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Nacional de Salta Sep 01 2011

Argentina

CONICET researcher :: Instituto de Investigaciones en Enfermedades Tropicales

Publications

Jaime Algorta, Stella Kepha, Alejandro Javier Krolewiecki, Hanbin Li, Justin Giang, Pedro Fleitas, Charles Mwandawiro, José Muñoz, null null
Population Pharmacokinetics and Exposure-Response Analysis of a Fixed-Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults. Clinical pharmacology and therapeutics (2024)
Alejandro Javier Krolewiecki, Wendemagegn Enbiale, Javier Gandasegui, Lisette Van Lieshout, Stella Kepha, Augusto Messa Junior, Michel Bengtson, Woynshet Gelaye Yalew, Valdemiro Escola, María Martinez-Valladares, María Cambra-Pellejà, Jaime Algorta, Helena Martí-Soler, Pedro Fleitas, Maria Rosa Ballester, Stephen R Doyle, Nana Aba Williams, Almudena Legarda, Inácio Mandomando, Charles Mwandawiro, José Muñoz
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates open research 6 (2022)
Alejandro Javier Krolewiecki, Wendemagegn Enbiale, Javier Gandasegui, Lisette Van Lieshout, Stella Kepha, Augusto Messa Junior, Michel Bengtson, Woynshet Gelaye Yalew, Valdemiro Escola, María Martinez-Valladares, María Cambra-Pellejà, Jaime Algorta, Helena Martí-Soler, Pedro Fleitas, Maria Rosa Ballester, Stephen R Doyle, Nana Aba Williams, Almudena Legarda, Inácio Mandomando, Charles Mwandawiro, José Muñoz
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates open research 6 (2022)
Alejandro Javier Krolewiecki, Wendemagegn Enbiale, Javier Gandasegui, Lisette Van Lieshout, Stella Kepha, Augusto Messa Junior, Michel Bengtson, Woynshet Gelaye Yalew, Valdemiro Escola, María Martinez-Valladares, María Cambra-Pellejà, Jaime Algorta, Helena Martí-Soler, Pedro Fleitas, Maria Rosa Ballester, Stephen R Doyle, Nana Aba Williams, Almudena Legarda, Inácio Mandomando, Charles Mwandawiro, José Muñoz
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates open research 6 (2022)
Woynshet Gelaye Yalew, Nana Aba Williams, Stella Kepha, Augusto Messa Junior, Pedro Emanuel Fleitas, Helena Martí-Soler, Destaw Damtie, Sissay Menkir, Alejandro Javier Krolewiecki, Lisette Van Lieshout, Wendemagegn Enbiale, null null
Performance evaluation of Baermann techniques: The quest for developing a microscopy reference standard for the diagnosis of Strongyloides stercoralis. PLoS neglected tropical diseases 15 (2) (2021)
Valeria Inés Segatori, Juan Garona, Lorena Grisel Caligiuri, Juan Bizzotto, Rosario Lavignolle, Ayelen Toro, Pablo Sanchis, Eduardo Spitzer, Alejandro Javier Krolewiecki, Geraldine Gueron, Daniel Fernando Alonso
Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients. Viruses 13 (10) (2021)
Daniel Camprubí, Alex Almuedo-Riera, Helena Martí-Soler, Alex Soriano, Juan Carlos Hurtado, Carme Subirà, Berta Grau-Pujol, Alejandro Javier Krolewiecki, Jose Muñoz
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients. PloS one 15 (11) (2020)
Matthew C Freeman, Oladele Akogun, Vicente Belizario, Simon J Brooker, Theresa W Gyorkos, Rubina Imtiaz, Alejandro Javier Krolewiecki, Seung Lee, Sultani Hadley Matendechero, Rachel L Pullan, Jürg Utzinger
Challenges and opportunities for control and elimination of soil-transmitted helminth infection beyond 2020. PLoS neglected tropical diseases 13 (4) (2019)
Jose Muñoz, Maria Rosa Ballester, Rosa Maria Antonijoan, Ignasi Gich, Montse Rodríguez, Enrico Colli, Silvia Gold, Alejandro Javier Krolewiecki
Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers. PLoS neglected tropical diseases 12 (1) (2018)
Alejandro Javier Krolewiecki
Misconceptions and paradoxes in soil-transmitted helminthiases control as a public health problem. PLoS neglected tropical diseases 12 (9) (2018)
Alejandro Javier Krolewiecki, Maria Cristina Almazan, Marcelo Quipildor, Marisa Juarez, Jose Fernando Gil, Marco Espinosa, Maria Canabire, Silvana Pamela Cajal
Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina. PLoS neglected tropical diseases 11 (10) (2017)
Carlos L Hoyos, Silvana P Cajal, Marisa Juarez, Jorge D Marco, Anahí M Alberti D'Amato, Melina Cayo, Irma Torrejón, Rubén O Cimino, Patricio Diosque, Alejandro Javier Krolewiecki, Julio R Nasser, José F Gil
Epidemiology of American Tegumentary Leishmaniasis and Trypanosoma cruzi Infection in the Northwestern Argentina. BioMed research international 2016 (2016)

Alejandro Javier Krolewiecki.css-eqlu8i{font-size:small;padding-left:4px;} (Alejandro Krolewiecki, Alejandro J Krolewiecki)

Publication Activity (10 Years)

Top Topics

Top Venues

Alejandro Javier Krolewiecki (Alejandro Krolewiecki, Alejandro J Krolewiecki)